Novavax (NVAX) Misses Q2 EPS by $12.03, Cuts FY Guidance
Tweet
Share
E-mail
Get Alerts NVAX Hot Sheet
Price: $9.74 +2.96%
EPS Growth %: -164.5%
Financial Fact:
Interest income: 554K
Today's EPS Names:
CRMT, More
EPS Growth %: -164.5%
Financial Fact:
Interest income: 554K
Today's EPS Names:
CRMT, More
Join SI Premium – FREE
Novavax (NASDAQ: NVAX) reported Q2 EPS of ($6.53), $12.03 worse than the analyst estimate of $5.50. Revenue for the quarter came in at $186 billion versus the consensus estimate of $1.02 billion.
GUIDANCE:
Novavax sees FY2022 revenue of $2-2.3 billion, versus the consensus of $4.27 billion.
For earnings history and earnings-related data on Novavax (NVAX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump said he was unaware of his earnings from crypto
- Isabella Bank added to Russell 2000 index after Nasdaq listing
- RBC Capital Upgrades GEA Group AG (G1A:GR) (GEAGY) to Outperform
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot Guidance, Trading HaltsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
